Orbital magnetic resonance imaging combined with clinical activity score can improve the sensitivity of detection of disease activity and prediction of response to immunosuppressive therapy for Graves' ophthalmopathy.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Endocrine journal

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1507/ENDOCRJ.K10E-156PMID 20733265
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Correlation of signal intensity ratio on orbital MRI-TIRM and clinical activity score as a possible predictor of therapy response in Graves’ orbitopathy—a pilot study at 1.5 T

  2010influential reference
• Graves' orbitopathy: current imaging procedures.

  2009influential reference
• Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO.

  2008cited by this paper
• Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease.

  2006cited by this paper
• Exophthalmos of patients with Graves' disease in Chinese of Taiwan

  2006cited by this paper
• Signal intensity, clinical activity and cross-sectional areas on MRI scans in thyroid eye disease

  2005cited by this paper
• Imaging of disease activity in Graves' orbitopathy with different methods: comparison of 99mTc-DTPA and 99mTc-depreotide single photon emission tomography, magnetic resonance imaging and clinical activity scores

  2005cited by this paper
• Role of Magnetic Resonance Imaging in the Assessment of Disease Activity in Thyroid-Associated Ophthalmopathy

  2002influential reference
• Serial STIR magnetic resonance imaging correlates with clinical score of activity in thyroid eye disease

  2001cited by this paper
• Controversies in the clinical evaluation of active thyroid‐associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment

  2001cited by this paper
• Assessment of disease activity in Graves' ophthalmopathy by orbital ultrasonography and clinical parameters

  2000cited by this paper
• Octreotide‐scintigraphy is a disease‐activity parameter in Graves' ophthalmopathy

  1999cited by this paper
• Clinical activity score as a guide in the management of patients with Graves' orbitopathy

  1997cited by this paper
• Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy

  1997cited by this paper
• Extraocular muscle changes in experimental orbital venous stasis: some similarities to graves' orbitopathy

  1996cited by this paper
• Extraocular muscles in Graves ophthalmopathy: usefulness of T2 relaxation time measurements.

  1994influential reference
• Graves’ ophthalmopathy in relation to cigarette smoking and ethnic origin

  1992cited by this paper
• Role of Magnetic Resonance Imaging in Thyroid-Associated Ophthalmopathy: Its Predictive Value for Therapeutic Outcome of Immunosuppressive Therapy

  1992influential reference
• Graves ophthalmopathy: role of MR imaging in radiation therapy.

  1991cited by this paper
• Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach.

  1989influential reference
• Racial differences in normal values of proptosis.

  1980cited by this paper
• Supervoltage orbital radiotherapy for Graves' ophthalmopathy.

  1973cited by this paper

• Role of DWI in evaluation of thyroid-associated orbitopathy

  2026cites this paper
• Orbital MRI and clinical activity score for predicting steroid treatment response in moderate-to-severe Graves’ orbitopathy

  2025cites this paper
• Assessment of disease activity in Graves’ orbitopathy

  2025cites this paper
• Application progress of magnetic resonance imaging in thyroid associated ophthalmopathy

  2025cites this paper
• The Value of MRI and Radiomics for the Diagnostic Evaluation of Thyroid-Associated Ophthalmopathy

  2025cites this paper
• MRI-based SIR quantitative biomarkers: a novel imaging diagnostic strategy for thyroid eye disease activity staging

  2025cites this paper
• Effectiveness of intravenous glucocorticoids in active thyroid eye disease patients with low clinical activity scores

  2025cites this paper
• Role of diffusion tensor imaging of extra ocular muscles and orbital fat in Graves’s ophthalmopathy and relation to disease activity

  2024cites this paper
• The evaluation of retrobulbar fat tissue in Graves’ orbitopathy with shear-wave ultrasound elastography

  2024cites this paper
• Whole-orbit-based multiparametric assessment of disease activity of thyroid eye disease on Dixon MRI

  2024cites this paper
• The diagnostic performance comparison between T2 mapping and Dixon against the activity of thyroid-associated ophthalmopathy: a systematic review and meta-analysis

  2024cites this paper
• Evaluation of fibroinflammatory activity in thyroid eye disease using [18F]AlF-NOTA-FAPI-04 PET/CT: A prospective study

  2024cites this paper
• Monocyte to high-density lipoprotein cholesterol ratio as a predictor of the activity of thyroid-associated ophthalmopathy.

  2024cites this paper
• Incidence of the postpartum diagnosis of thyroid eye disease in relation to thyroid function in Graves’ disease

  2024cites this paper
• The efficacy and safety of selenium supplementation versus placebo in the treatment of Graves' orbitopathy: A systematic review and meta‐analysis of randomised controlled trials

  2024cites this paper
• COVID-19 vaccination might be associated with asymmetric thyroid eye disease

  2024cites this paper
• Computer aided volumetric assessment of orbital structures in patients with Graves' orbitopathy: correlation with serum thyroid antiperoxidase antibodies and disease activity

  2023cites this paper
• The Role of Thermal Camera in the Assessment of Thyroid Eye Disease Activity

  2023cites this paper
• Predictive markers for anti-inflammatory treatment response in thyroid eye disease

  2023cites this paper
• Dysthyroid Optic Neuropathy

  2023cites this paper
• Magnetic Resonance Imaging in the Management of Thyroid Eye Disease: A Systematic Review

  2023cites this paper
• Optic nerve sheath infiltration in dysthyroid optic neuropathy

  2023cites this paper
• Application of Quantitative MRI in Thyroid Eye Disease: Imaging Techniques and Clinical Practices

  2023cites this paper
• Deep learning-based diagnosis of disease activity in patients with Graves’ orbitopathy using orbital SPECT/CT

  2023cites this paper
• Use of extreme gradient boosting, light gradient boosting machine, and deep neural networks to evaluate the activity stage of extraocular muscles in thyroid-associated ophthalmopathy

  2023cites this paper
• Morphometric and volumetric analysis of lacrimal glands in patients with thyroid eye disease

  2023cites this paper
• Incidence and risk factors for Graves' orbitopathy in patients who underwent anti-inflammatory and immunosuppressive treatment during medical treatment for Graves' disease: investigation of 1,553 cases with newly diagnosed Graves' disease and proposal of a predictive score.

  2023cites this paper
• High IgG4 serum concentration is associated with active Graves orbitopathy

  2023influential citation
• Application of Multiparameter Quantitative Magnetic Resonance Imaging in the Evaluation of Graves' Ophthalmopathy

  2023cites this paper
• Evaluation of activity of Graves’ orbitopathy with multiparameter orbital magnetic resonance imaging (MRI)

  2023cites this paper
• MRI in the assessment of thyroid-associated orbitopathy activity.

  2022cites this paper
• TSAb/TRAb ratio as a sensitive screening test for active Graves' orbitopathy.

  2022cites this paper
• Role of orbital magnetic resonance imaging in early detection of graves’ orbitopathy and disease activity

  2022cites this paper
• Annals of Clinical and Medical Case Reports Radiation Therapy of Thyroid-related Eye Diseases

  2022cites this paper
• Role of Peripheral Regulatory T Lymphocytes in Patients with Thyroid Associated Ophthalmopathy During Systemic Glucocorticoid Treatment: A Prospective Observational Study

  2022cites this paper
• Current insights of applying MRI in Graves’ ophthalmopathy

  2022cites this paper
• Thermal Imaging of the Ocular Surface in Thyroid Eye Disease: A Comparison between Active, Inactive and Healthy Eyes

  2021cites this paper
• [Clinical Analysis of 2 170 Cases of Thyroid-Associated Ophthalmopathy Involving Extraocular Muscles].

  2021cites this paper
• Expanding diagnostic tools for dysthyroid optic neuropathy: how quantitative MRI can be used to visualize and measure orbital inflammation

  2021cites this paper
• Dixon-T2WI magnetic resonance imaging at 3 tesla outperforms conventional imaging for thyroid eye disease

  2021cites this paper
• An Interesting Case of Euthyroid Graves’ Ophthalmopathy, With Negative Thyroid-Stimulating Hormone Receptor Antibodies

  2021cites this paper
• Thyroid Eye Disease

  2021cites this paper
• Corneal Endothelium:A Promising Quantitative Index for Graves Ophthalmopathy Activity Evaluation.

  2021cites this paper
• Advances in magnetic resonance imaging of orbital disease.

  2021cites this paper
• Evaluation of extraocular muscles in patients with thyroid associated ophthalmopathy using apparent diffusion coefficient measured by magnetic resonance imaging before and after radiation therapy

  2021cites this paper
• Application of Magnetic Resonance Imaging in the Evaluation of Disease Activity in Graves' Ophthalmopathy.

  2020cites this paper
• Reply re: "Noninflammatory Thyroid Eye Disease".

  2020cites this paper
• Low signal intensities of MRI T1 mapping predict refractory diplopia in Graves’ ophthalmopathy

  2020cites this paper
• [Influence of CYP3A4, CYP3A5, and NR3C1 genes polymorphism on the effectiveness of glucocorticoid therapy in patients with endocrine ophthalmopathy].

  2020cites this paper
• Value of Infrared Thermography Camera Attached to a Smartphone for Evaluation and Follow-up of Patients with Graves' Ophthalmopathy

  2019cites this paper
• 99mTc-DTPA SPECT/CT provided guide on triamcinolone therapy in Graves’ ophthalmopathy patients

  2019cites this paper
• ROLE OF MAGNETIC RESONANCE IMAGING IN THE ASSESSMENT OF ACTIVE THYROID-ASSOCIATED OPHTHALMOPATHY PATIENTS WITH LONG DISEASE DURATION.

  2019cites this paper
• Predictive factors of prognosis after radiation and steroid pulse therapy in thyroid eye disease

  2019cites this paper
• Triamcinolone for the Treatment of Graves Ophthalmopathy Tested With Short Tau Inversion Recovery Magnetic Resonance.

  2019cites this paper
• Diffusion-weighted magnetic resonance imaging of extraocular muscles in patients with Grave's ophthalmopathy using turbo field echo with diffusion-sensitized driven-equilibrium preparation.

  2018cites this paper
• Comparison of exophthalmos measurements: Hertel exophthalmometer versus orbital parameters in 2-dimensional computed tomography.

  2018cites this paper
• Thyroid eye disease: a 2017 update from the first thyroid eye clinic in Hong Kong

  2017cites this paper
• Comparison of two different regimens of intravenous methylprednisolone for patients with moderate to severe and active Graves' ophthalmopathy: a prospective, randomized controlled trial.

  2017influential citation
• MRI of Orbital Pathology : An Overview for the Ophthalmologist

  2017cites this paper
• Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves’ ophthalmopathy

  2017cites this paper
• Three dimensional orbital magnetic resonance T2-mapping in the evaluation of patients with Graves’ ophthalmopathy

  2017cites this paper
• New opportunities in endocrine ophthalmopathy diagnostics (review)

  2017cites this paper
• Quantitative Analysis of Inflammation in Orbital Fat of Thyroid-associated Ophthalmopathy Using MRI Signal Intensity

  2017cites this paper
• Dysthyroid optic neuropathy: update on pathogenesis, diagnosis, and management

  2017cites this paper
• Performance of apparent diffusion coefficient of medial and lateral rectus muscles in Graves' orbitopathy

  2017cites this paper
• Using Nonechoplanar Diffusion-weighted MRI to Assess Treatment Response in Active Graves Orbitopathy: A Novel Approach with 2 Case Reports.

  2016cites this paper
• Investigation of candidate biomarkers in Graves' disease and thyroid-associated ophthalmopathy

  2016cites this paper
• Overall safety and efficacy of high-dose and low-dose intravenous glucocorticoid therapy in patients with moderate-to-severe active Graves' ophthalmopathy.

  2016cites this paper
• Relationship between magnetic resonance imaging signal intensity and volume of extraocular muscles in thyroid-associated ophthalmopathy with methylprednisolone pulse therapy

  2016cites this paper
• Imaging Evaluation of the Orbit in Graves Ophthalmopathy

  2015cites this paper
• Circulating microRNA predicts insensitivity to glucocorticoid therapy in Graves’ ophthalmopathy

  2015cites this paper
• Graves' ophthalmopathy: the role of diffusion-weighted imaging in detecting involvement of extraocular muscles in early period of disease.

  2015cites this paper
• Radioiodine-Associated Exacerbation of Graves' Orbitopathy in the Japanese Population: Randomized Prospective Study.

  2015cites this paper
• Diagnostic accuracy of short-time inversion recovery sequence in Graves’ ophthalmopathy before and after prednisone treatment

  2014influential citation
• Graves’ Ophthalmopathy Imaging Evaluation

  2014cites this paper
• Assessment of Medial and Inferior Extraocular Muscle Thickness by Ultrasonography in Juvenile Patients with Graves’ Disease

  2014cites this paper
• Novel thermal imaging analysis technique for detecting inflammation in thyroid eye disease.

  2014influential citation
• Correlation between magnetic resonance imaging and ultrasound measurements of eye muscle thickness in thyroid-associated orbitopathy.

  2014cites this paper
• Graves' ophthalmopathy: epidemiology and natural history.

  2014cites this paper
• Disease Activity in Graves' Ophthalmopathy: Diagnosis with Orbital MR Imaging and Correlation with Clinical Score

  2013cites this paper
• CT features of exophthalmos in Chinese subjects with thyroid-associated ophthalmopathy.

  2013cites this paper
• La tomografía computarizada y la resonancia magnética en patologías frecuentes de órbita y vía óptica. Una revisión

  2013cites this paper
• Normative measurements of extraocular musculature by multislice computed tomography.

  2012cites this paper
• Imaging studies for diagnosing Graves' orbitopathy and dysthyroid optic neuropathy

  2012cites this paper
• Signal intensity and T2 time of extraocular muscles in assessment of their physiological status in MR imaging in healthy subjects

  2012cites this paper
• Evaluation of rectus extraocular muscles using dynamic contrast-enhanced MR imaging in patients with Graves' ophthalmopathy for assessment of disease activity

  2012cites this paper
• 99mTc-Anti-TNF-α scintigraphy: a new perspective within different methods in the diagnostic approach of active Graves ophthalmopathy.

  2012cites this paper
• [Thyroid ophthalmopathy at the time of European Group On Graves Orbitopathy (EUGOGO)].

  2011cites this paper
• Clinical Ophthalmology Dovepress Dovepress Clinical and Imaging Evaluation of the Response to Intravenous Steroids in Patients with Graves' Orbitopathy and Analysis on Who Requires Additional Therapy

  year unknowncites this paper